Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Cancer Research|March 8, 2000
Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancerT A Lehman, B G Haffty, C J Carbone, et al.
Cancer Research|December 16, 1998
Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathwaysB C Turner, J Zhang, A A Gumbs, et al.
Radiation Oncology Investigations|January 1, 1997
Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neckB G Haffty, Y H Son, L D Wilson, et al.
The Cancer Journal From Scientific American|August 10, 1999
Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community settingB Burtness, S Windsor, B Holston, et al.
Cancer Research|August 1, 1997
Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiationB C Turner, B G Haffty, L Narayanan, et al.
Annals of Surgical Oncology|February 25, 2014
Basal subtype, as approximated by triple-negative phenotype, is associated with locoregional recurrence in a case-control study of women with 0-3 positive lymph nodes after mastectomyA J Khan, S A Milgrom, N Barnard, et al.
Cancer|October 1, 1991
Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinomaA H Frank, P C Tseng, B G Haffty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-upA Psyrri, M Kwong, S DiStasio, et al.
The Cancer Journal From Scientific American|May 1, 1996
Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiationL J Solin, B McCormick, A Recht, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 1998
Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapyB C Turner, J P Knisely, B M Kacinski, et al.
Pageof 9